CHTR vs CYTK · P/E 11, rev $55.09B vs rev $88.0M
Charter Communications Inc (CHTR) versus Cytokinetics Inc (CYTK) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported CYTK revenue for 2025-12-31 was $88.0M. Net income was -$785.0M. Revenue was up 376.6% from 2024-12-31 to 2025-12-31. CYTK currently screens at market cap $4.05B.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. CYTK currently screens at market cap $4.05B.
Not investment advice. Open the CHTR and CYTK stock pages for the full models.
Not investment advice.